The Education Advisory Board took charge of supervising and reviewing all the theoretical contents of the Master's Programme.

MEMBERS OF THIS BOARD:

AUSTRIA

Prof. Heinz Redl
Founder and CEO. Trauma Care Consult. Former Director Ludwig Boltzmann lnstitute for Experimental and Clinical Traumatology. Coordinator Austrian Cluster for Tissue Regeneration. Continental Chair- Europe of TERMIS. Associated Professor Technical University Vienna, lnstitute for Chemical Engineering.

FINLAND

Dr. Paula Salmikangas
Director of Biopharmaceuticals and ATMPs. NDA Group AB. Adjunct Professor University of Helsinki, Faculty of Biological and Environmental Sciences. Former Research Professor. Finnish Medicines Agency. Former Chair of the Committee for Advanced Therapies (CAT), EMA. Former Chair of the Cell Based Products Working Party (CPWC), EMA

FRANCE

Prof. Marina Cavazzana-Calvo
Head of the Haematology Department and Head Clinical Research Centre in Biotherapy. Necker-Enfants Malades Hospital. Former Director. Institut National de la Santé et de la Recherche Médicale (INSERM)

GERMANY

Prof. C. James Kirkpatrick
Emeritus Professor of Pathology. University Medical Center. Johannes Gutenberg University.

Prof. Dietger Niederwieser
Professor of Medicine, Head of the Division of Haematology & Medical Oncology. University Hospital Leipzig. Past President Worldwide Network for Blood & Marrow Transplantation. Past-president European Group for Blood and Marrow Transplantations.

ITALY

Dr. Michele De Luca
Director Interdepartmental Centre for Stem Cell and Regenerative Medicine "Stefano Ferrari". University of Modena and Reggio Emilia. Full Professor of Biochemistry. University of Modena and Reggio Emilia. Scientific Director of Holostem Terapie Avanzate S.r.l.

Dr. Maria Cristina Galli
Senior Researcher at lstituto Superiore di Sanitá. Chair of the ATMP Platform EATRIS. Former Member of the Committee for Advanced Therapies [CAT], EMA. Former Chair of Gene Therapy Working Group, EMA.

Dr. Martino lntrona
Head Scientific Program Laboratorio di Terapia Cellulare e Genica "G. Lanzani". Department of Haematology. Ospedali Riuniti di Bergamo. Former Chair Legal and Regulatory Affairs Committee-Europe [ISCT].

Dr. Giovanni Migliaccio
Scientific Director. Centro Valutazioni Biologiche e Farmacologiche, (CVBF Pavia, IT). Head of the section "Gene and Cell Therapy". Department of Cell Biology and Neuroscience. lstituto Superiore di Sanita, Rome. Senior Advisor. EATRIS Amsterdam.

PORTUGAL

Prof. Rui L. Reís
Vice-Rector/President for Research. University of Minho, Braga & Guimaraes. Director 3B's Research Group. Biomaterials, Biodegradables and Biomimetics. Dept. of Polymer Engineering, University of Minho. CEO of the European lnstitute of Excellence on Tissue Engineering and Regenerative Medicine. Portuguese Government Associate Laboratory ICVS/3 B's.

Prof. Beatriz Silva Lima
Chair of the IMI [EU/EFPIA) Scientific Committee. Coordinator of the Pharmacological Sciences Research Group, Professor and Member of the Executive Board. IMED University of Lisbon. Member NDA Advisory Board. NDA Group AB. Former Member of the Committee for Advanced Therapies [CAT], EMA.Former Chair of the Safety Working Party [SWP). EMA.

SPAIN

Prof. Cecilia Gómez-Salvago
Professor of Civil Law. Universidad de Sevilla.

Prof. Jose López-Barneo
Professor of Physiology. Former Drector of Instituto de Biomedicina de Sevilla (IBiS)
Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla.

THE NETHERLANDS

Dr. Ineke Slaper-Cortenbach
Head of the Cell Therapy Facility. Dpt. Clinical Pharmacy. UMC Utrecht.

UNITED KINGDOM

Dr. Timothy Allsopp
Founder and Managing Director of Consilium Bio Ltd. Former Head of External Research. Neusentis Regenerative Medicine. Pfizer Ltd.

Dr. Glyn Stacey
Director for the UK Stem Cell Bank. CEO of SSCBIO Ltd. Former Head of Division of Cell Biology and lmaging, NIBSC.

Prof. Adrian Thrasher
Wellcome Trust Senior Clinical Fellow. NIHR Senior lnvestigator. Honorary Consultant lmmunologist GOSH. Director of Centre for lmmunodeficiency. Director of Gene Therapy Programme ICH/GOSH. UCL lnstitute of Child Health.

U.S.A.

Dr. Gregory A. Bonfiglio
Founder and Managing Partner of Proteus LLC. Chairman of the Board of the Centre for Commercialization of Regenerative Medicine. RM Translation Center (Canada). Member of ISSCR. Member of ISCT.

Prof. Jose Cibelli
Head of Cellular Reprogramming Laboratory, Michigan State University. Former Scientific Director LARCel-Seville (Spain]

Prof. Pete Coffey
Professor Neuroscience Research lnstitute. University of California. Director of the London Project to Cure Blindness. Moorfields Eye Hospital. Professor at Institute of Ophthalmology. UCL

Dr. Michael C. Holmes
SVP & Chief Technology Officer. Sangamo Therapeutics, Inc. Former Vice President. Research. Sangamo BioSciences, lnc.

Dr. Jane S. Lebkowski
President of Research and Development at Regenerative Patch Technologies (California). Former President of R&D. Asterías Biotherapeutics. Advisor of BEAT Biotherapeutics Corp.